AMRIZE LTD
AMRZ · NYSE
Updated at 2026-10-13 14:04:20
- Today's High
- $36.35
- Today’s Low
- $35.97
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $36.28
- Previous Close
- $36.09
- Volume
- 2.18M
- Market Cap
- $19.73B
- P/E Ratio
- 16.38X
- EPS
- $2.17
Previous Day Range
52-Week Range
Company Overview
- Sector
- BASIC MATERIALS
- Industry
- Construction
- Sub-industry
- BUILDING MATERIALS
- Headquarters
- GRAFENAUWEG 8, ZUG, SWITZERLAND, 6300
- Country
- US
- Listing Date
- 2025-06-23
- Fiscal Year End
- December
- Shares Outstanding
- 553.54M
- CIK
- --
- Website
- www.amrize.com
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Financial Metrics
Revenue
2026-06-30
$3.49B
2026-03-31
$2.17B
2025-12-31
$2.83B
2025-09-30
$3.67B
Operating Expenses
2026-06-30
$283M
2026-03-31
$292M
2025-12-31
$278M
2025-09-30
$312M
Net Income
2026-06-30
$478M
2026-03-31
-$116M
2025-12-31
$298M
2025-09-30
$545M
Net Profit Margin
2026-06-30
13.68%
2026-03-31
-5.32%
2025-12-31
10.49%
2025-09-30
14.82%
Earnings Per Share
2026-06-30
$0.88
2026-03-31
$-0.21
2025-12-31
$0.62
2025-09-30
$1.13
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$967M
2026-03-31
$161M
2025-12-31
$717M
2025-09-30
$1B
Effective Tax Rate
2026-06-30
23.47%
2026-03-31
18.62%
2025-12-31
25.12%
2025-09-30
21.64%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $3.49B | $2.17B | $2.83B | $3.67B |
| Operating Expenses | $283M | $292M | $278M | $312M |
| Net Income | $478M | -$116M | $298M | $545M |
| Net Profit Margin | 13.68% | -5.32% | 10.49% | 14.82% |
| Earnings Per Share | $0.88 | $-0.21 | $0.62 | $1.13 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $967M | $161M | $717M | $1B |
| Effective Tax Rate | 23.47% | 18.62% | 25.12% | 21.64% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.